Thermo Fisher price target raised to $670 from $630 at Goldman Sachs
Goldman Sachs analyst Matthew Sykes raised the firm’s price target on Thermo Fisher (TMO) to $670 from $630 and keeps a Buy rating on the ...
StockStory.org on MSN10h
Thermo Fisher’s (NYSE:TMO) Q4 Sales Beat Estimates
Life sciences company Thermo Fisher (NYSE:TMO) reported Q4 CY2024 results , with sales up 4.7% year on year to $11.4 billion.
Thermo Fisher Stock Surges as Medical Device Maker's Results Top Estimates
Shares of Thermo Fisher Scientific jumped Thursday after the company's fourth-quarter results topped estimates, as sales increased across all four of its divisions.
Earnings call transcript: Thermo Fisher Scientific beats Q4 2024 forecasts
Thermo Fisher Scientific Inc. (NYSE:TMO) surpassed analyst expectations for the fourth quarter of 2024, reporting higher-than-anticipated earnings per share (EPS) and revenue. The company's stock rose ...
Thermo Fisher higher despite in-line 2025 guidance
Thermo Fisher Scientific (TMO) stock gains as the company beats Q4 2024 expectations and sets 2025 earnings outlook in line ...
Thermo Fisher Q4 Earnings Beat Estimates, Margin Expands
Thermo Fisher Scientific (TMO) reports Q4 earnings of $6.10 per share, exceeding expectations. Operating income and revenue growth also increased.
Thermo Fisher’s Strong Q4 Performance and Strategic Positioning Justify Buy Rating
Michael Ryskin, an analyst from Bank of America Securities, maintained the Buy rating on Thermo Fisher (TMO – Research Report). The associated ...
Thermo Fisher Beats Quarterly Estimates on Strong Demand for Its Tools and Services
Earlier this week, Franco-German peer Sartorius reported preliminary annual results that beat expectations and posted a 23.1% ...